Search Results
21 items found for "HMG-CoA reductase"
Posts (19)
- Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in...
endpoint, with KarXT demonstrating a statistically significant and clinically meaningful 9.6-point reduction KarXT also demonstrated an early and sustained statistically significant reduction of symptoms, as assessed by PANSS total score, starting at Week 2 and maintained such reduction through all timepoints in the
- Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
Evaluating Valbenazine for Chorea Associated with Huntington Disease " Highly Statistically Significant Reduction Huntington's Disease Rating Scale (UHDRS®) Total Maximal Chorea (TMC) Score- Placebo-Adjusted Mean Reduction The study met the primary endpoint of reduction in severity of chorea, the cardinal motor feature in
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
multiple neuroinflammatory disease models Discovery of a potent melatonin-based inhibitor of quinone reductase
Other Pages (2)
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
achieved complete remission, with or without hematologic count recovery (CR/CRi), and 32% exhibited a ≥50% reduction
- Session VI | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
ADC in patient-derived GBM xenografts in the brain of immunodeficient mice resulted in significant reduction